Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.356,59
-1,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Accelerate Diagnostics Inc (AXDX) Accelerate Diagnostics Inc (AXDX) Notizie

AXDX

Accelerate Diagnostics (AXDX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXDX
DataOraFonteTitoloSimboloCompagnia
22/05/202401:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXDXAccelerate Diagnostics Inc
13/05/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXDXAccelerate Diagnostics Inc
10/05/202423:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
08/05/202422:42PR Newswire (US)Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
02/05/202415:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
28/03/202421:05PR Newswire (US)Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
07/03/202415:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.NASDAQ:AXDXAccelerate Diagnostics Inc
05/03/202421:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXDXAccelerate Diagnostics Inc
23/01/202403:59Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AXDXAccelerate Diagnostics Inc
19/01/202415:20PR Newswire (US)Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementNASDAQ:AXDXAccelerate Diagnostics Inc
18/01/202413:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
16/01/202413:45PR Newswire (US)Accelerate Diagnostics Announces Launch of Proposed Public OfferingNASDAQ:AXDXAccelerate Diagnostics Inc
08/01/202402:00PR Newswire (US)Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
13/12/202323:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AXDXAccelerate Diagnostics Inc
27/11/202315:15PR Newswire (US)Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202323:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202322:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/10/202314:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
10/08/202322:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
27/07/202315:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
11/07/202302:04Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/07/202315:00PR Newswire (US)Accelerate Diagnostics Announces 1-for-10 Reverse Stock SplitNASDAQ:AXDXAccelerate Diagnostics Inc
30/06/202300:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXDXAccelerate Diagnostics Inc
21/06/202312:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AXDXAccelerate Diagnostics Inc
20/06/202323:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202316:57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202315:00PR Newswire (US)Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform WaveNASDAQ:AXDXAccelerate Diagnostics Inc
02/06/202300:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXDXAccelerate Diagnostics Inc
31/05/202322:11Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:AXDXAccelerate Diagnostics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXDX

La tua Cronologia

BOV
MSPA3
MELHOR SP ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network